Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 781-792 of 1,136
Drug study icon
TerminatedNCT04708834

Long-term Safety Study of Adjunctive Troriluzole in Subjects With OCD

This study exists to better understand the safety of the medication Adjunctive and how manageable it feels in practice. For people living with OCD, that matters because care needs to work in daily life, not just in theory.

In Canada
OCDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT00190684

Long-Term, Open Label Atomoxetine Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
ADHDDrugFrom 6 Years to 18 Years
Countries
United States, Australia, France, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Behavioral study icon
CompletedNCT05204940

Longitudinal Observational Biomarker Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
DepressionBehavioralOver 60 Years
Countries
United States, Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In Canada
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02147379

Lurasidone and Cognition in Bipolarity type I

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
BipolarityDrugFrom 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity
Drug study icon
CompletedNCT01485640

Lurasidone Extended Use Study

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

In Canada
Schizophrenia, BipolarityDrug
Countries
France, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity
Other study type icon
Enrolling By InvitationNCT06978881

Magnetoencephalography in Psychosis Program

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.